IRIS
BERNARDINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.706
EU - Europa 9.212
AS - Asia 4.550
SA - Sud America 716
AF - Africa 247
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.558
GB - Regno Unito 2.410
RU - Federazione Russa 1.621
CN - Cina 1.526
SG - Singapore 1.401
IT - Italia 1.270
IE - Irlanda 1.016
DE - Germania 628
BR - Brasile 614
SE - Svezia 589
UA - Ucraina 567
VN - Vietnam 507
FR - Francia 490
HK - Hong Kong 320
FI - Finlandia 236
KR - Corea 223
IN - India 149
TR - Turchia 104
ZA - Sudafrica 95
ES - Italia 74
CA - Canada 71
NL - Olanda 64
CI - Costa d'Avorio 56
BD - Bangladesh 54
MX - Messico 45
PL - Polonia 44
AR - Argentina 43
BE - Belgio 43
NG - Nigeria 41
CZ - Repubblica Ceca 39
JP - Giappone 35
IQ - Iraq 33
AT - Austria 32
ID - Indonesia 28
PK - Pakistan 25
IR - Iran 23
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 13
JO - Giordania 13
PT - Portogallo 13
AU - Australia 12
AZ - Azerbaigian 12
EC - Ecuador 12
KE - Kenya 12
LT - Lituania 12
TN - Tunisia 11
CO - Colombia 10
MA - Marocco 10
VE - Venezuela 10
BO - Bolivia 9
CH - Svizzera 9
CR - Costa Rica 9
EE - Estonia 9
EG - Egitto 9
RO - Romania 9
SA - Arabia Saudita 9
EU - Europa 8
MY - Malesia 8
PE - Perù 8
AM - Armenia 6
NZ - Nuova Zelanda 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NO - Norvegia 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
CL - Cile 4
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
PA - Panama 4
PY - Paraguay 4
BG - Bulgaria 3
BY - Bielorussia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
PH - Filippine 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AL - Albania 2
DK - Danimarca 2
DZ - Algeria 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 26.442
Salva come PNG Salva come JPEG
Città #
Southend 2.135
Dallas 1.406
Fairfield 1.176
Menlo Park 1.053
Dublin 1.002
Singapore 840
Ashburn 786
Chandler 663
Woodbridge 526
Jacksonville 465
Moscow 442
Siena 428
Wilmington 412
Santa Clara 409
Seattle 397
Cambridge 391
Houston 390
Beijing 346
San Jose 331
Ann Arbor 317
Hong Kong 304
Hefei 257
Seoul 218
Princeton 206
Nanjing 158
Los Angeles 153
Ho Chi Minh City 150
Milan 140
The Dalles 140
New York 139
Helsinki 126
Council Bluffs 125
Boardman 100
Hanoi 100
Lauterbourg 99
Johannesburg 84
Munich 83
Izmir 74
Florence 73
San Mateo 70
Dearborn 68
San Diego 64
Shanghai 64
São Paulo 57
Abidjan 56
Buffalo 55
Nanchang 54
Columbus 51
Lancaster 49
Bengaluru 47
Dong Ket 44
Orem 43
London 42
Shenyang 42
Brussels 41
Abuja 40
Fremont 39
Warsaw 39
Málaga 38
Frankfurt am Main 35
Tianjin 33
Changsha 30
Haiphong 30
Da Nang 29
Stockholm 29
Hebei 28
Redwood City 28
Rome 26
Redondo Beach 25
Rio de Janeiro 25
Phoenix 24
Tokyo 24
Brno 23
Toronto 23
Denver 22
Kunming 22
Vienna 22
Brooklyn 21
Chicago 21
Jinan 21
Mexico City 19
Poplar 19
Turku 19
Atlanta 18
Jiaxing 18
Belo Horizonte 17
Jakarta 17
Manchester 17
Montreal 17
Zhengzhou 17
Amsterdam 16
Boston 16
Hangzhou 16
Washington 16
Monteroni D'arbia 15
Ningbo 15
San Francisco 15
Tashkent 15
Chennai 14
Mumbai 14
Totale 18.518
Salva come PNG Salva come JPEG
Nome #
Chondroptosis in alkaptonuric cartilage 486
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 482
Amyloidosis, Inflammation, and Oxidative Stress in the Heart of an Alkaptonuric Patient 403
Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria 401
4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases 397
Biochemical and proteomic characterization of alkaptonuric chondrocytes 384
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 375
Novel smoothened antagonists as anti-neoplastic agents for the treatment of osteosarcoma 373
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 367
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria 365
CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration 363
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: preliminary in vitro studies with analogues of immucillin-G 357
Beer promotes differentiation and mineralization of human osteoblastic cells: Role of silicon 351
Alkaptonuria is a novel human secondary amyloidogenic disease 347
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 344
Angiogenesis in alkaptonuria 340
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project 335
Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. 318
Diagnosis of secondary amyloidosis in alkaptonuria 302
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure 299
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 299
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. 298
A proteomic study of human osteoblastic cells proliferation and differentiation 298
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 296
Quick Diagnosis of Alkaptonuria by Homogentisic Acid Determination in Urine Paper Spots 292
Application of proteomics to the study of Helicobacter pylori and implications for the clinic 292
Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria 288
Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1,2-dioxygenase mutants at the base of rare disease Alkaptonuria 288
Amyloidosis in alkaptonuria 286
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 284
Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins 283
A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence (LEXRF) microscopy correlative study on a rare disease 283
Proteomic investigation of dermal fibroblasts isolated from affected and unaffected skin samples from patients with limited cutaneous systemic sclerosis: 2 distinct entities? 279
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes 278
Wild-type wine Saccharomyces cerevisiae as a tool to evaluate the effects on eukaryotic life of locally used herbicides 271
Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease 271
Modern proteomic methodologies for the characterization of lactosylation protein targets in milk 267
Secondary amyloidosis in an alkaptonuric aortic valve 266
Machine learning application for development of a data-driven predictive model able to investigate quality of life scores in a rare disease 266
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 265
Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria 264
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis 263
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis 262
Antibacterial activity of grape extracts towards cagA positive and cagA negative Helicobacter pylori clinical isolates 260
Conformations and biological activities of Amyloid Beta Peptide 25-35 257
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria 256
Oxidative stress and mechanisms of ochronosis in alkaptonuria 254
Antimicrobial efficacy of five probiotic strains against Helicobacter pylori 251
Saccharomyces cerevisiae as a Tool to Evaluate the Effects of Herbicides on Eukaryotic Life 250
Pro-Apoptotic activity of French Polynesian Padina pavonica Extract on Human Osteosarcoma Cells 248
Helicobacter pylori infection and autoimmune thyroid diseases: The role of virulent strains 246
Helicobacter pylori: immunoproteomics related to different pathologies 244
Mapping phosphoproteins in Neisseria meningitidis serogroup A 240
Animal and cell models for Lesch-Nyhan syndrome 239
Inactivation of Helicobacter pylori cagA gene affects motility 238
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells. 237
Padina pavonica Extract Promotes In Vitro Differentiation and Functionality of Human Primary Osteoblasts 237
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure 235
Oxidative damage mediated by herbicides on yeast cells 235
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain 231
Alkaptonuria 225
Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt/β-catenin signaling pathway 224
Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer 222
Proteomics of osteosarcoma 221
TREATMENT OF ALKAPTONURIA AND TYROSINEMIA TYPE 1 221
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model 220
Foodomics for human health: current status and perspectives 220
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcoma 205
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria 205
Metodologia dell’elettroforesi bidimensionale 204
Post-genomics of bone metabolic dysfunctions and neoplasias 199
Treatment of alkaptonuria and tyrosinemia type I 197
Expanding the proteome database of Meningococcus A 196
Saccharomyces cerevisiae as a model in ecotoxicological studies: a post-genomics perspective 194
Oxidative damage induced by herbicides is mediated by thiol oxidation and hydroperoxides production 191
Surfome analysis of a wild-type wine Saccharomyces cerevisiae strain 189
Postgenomics of Neisseria meningitidis: An update 188
Identification of new epidemiological molecular markers by comparative proteomics of serogroup A meningococcal isolates from three pandemic waves 186
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 183
Bacterial post-genomics approaches for vaccines development 180
Tumor-associated macrophages in Osteosarcoma: from mechanisms to therapy 177
Western blotting on total lysate of Helicobacter pylori 176
Linking protein oxidation to environmental pollutants: redox proteomic approaches 173
Post-genomics and skin inflammation 168
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies 165
The therapy for Helicobacter pylori eradication 165
Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies 163
Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype 160
Rubus ulmifolius Leaf Extract Inhibits Proliferation of Murine Myeloma Cells 157
Diagnosis of Helicobacter pylori infection 153
Proteomics of metronidazole resistance in clinical isolates of Helicobacter pylori 149
null 145
Postgenomics of Neisseria meningitidis for vaccines development 144
Surface properties of nanocrystalline TiO2 coatings in relation to the in vitro plasma protein adsorption 144
Omics and rare diseases: challenges, applications, and future perspectives 143
The analysis of Neisseria meningitidis proteomes: reference maps and their applications 143
Leveraging proteomics in orphan disease research: pitfalls and potential 142
Proteome analysis of Neisseria meningitidis serogroup A 139
Identification of Helicobacter pylori proteins involved in metronidazole resistance by comparative proteomic analysis 136
Inborn errors of purine salvage and catabolism 132
Totale 25.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021776 0 0 0 0 0 0 0 0 0 414 192 170
2021/20221.837 147 206 116 131 90 68 94 81 101 242 190 371
2022/20232.244 133 217 282 320 216 438 47 195 218 54 69 55
2023/20241.654 66 33 156 74 65 452 535 43 8 18 37 167
2024/20253.330 64 193 383 185 391 195 159 226 315 109 335 775
2025/20267.580 560 1.083 1.214 1.011 1.630 278 945 206 277 376 0 0
Totale 26.759